Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center

Clinical Rheumatology

Volumn 30, Issue 10, 2011, Pages 1311-1317

  Keeling, Stephanie O ^a   Teo, Michelle ^a   Fung, Daisy ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiovascular risk reduction; Framingham risk score; Inflammatory arthritis; Systemic lupus erythematosus

Indexed keywords

ABATACEPT; ACETYLSALICYLIC ACID; ADALIMUMAB; ANTIHYPERTENSIVE AGENT; ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; CELL NUCLEUS ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOOXYGENASE 2 INHIBITOR; DOUBLE STRANDED DNA; ETANERCEPT; GOLD; HYPOCHOLESTEROLEMIC AGENT; INFLIXIMAB; LEFLUNOMIDE; LUPUS ANTICOAGULANT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; ANEMIA; ANTIBODY BLOOD LEVEL; ARTHRITIS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; DYSLIPIDEMIA; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; FEMALE; FRAMINGHAM RISK SCORE; HEART INFARCTION; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DISEASE; LEUKOPENIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MOUTH ULCER; NEUROLOGIC DISEASE; OBESITY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SEX RATIO; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE; THROMBOCYTOPENIA;

EID: 85027944774     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1747-9     Document Type: Article

References (32)

1. Y Shoenfeld R Gerli A Doria, et al. 2005 Accelerated atherosclerosis in autoimmune rheumatic diseases Circulation 112 3337 3347 16301360 10.1161/CIRCULATIONAHA.104.507996 (Pubitemid 43739380)
2. MT Nurmohamed 2009 Cardiovascular risk in rheumatoid arthritis Autoimmun Rev 8 663 667 19393192 10.1016/j.autrev.2009.02.015
3. E Bartoloni Bocci F Luccioli C Angrisani S Moscatelli A Alunno R Gerli 2007 Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseases Expert Rev Clin Immunol 3 531 541 20477158 10.1586/1744666X.3.4.531 1:CAS:528:DC%2BD2sXntFynu70%3D (Pubitemid 47091230)
4. C Meune E Touzé L Trinquart Y Allanore 2009 Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies Rheumatol (Oxford) 48 1309 1313 10.1093/rheumatology/kep252
5. F Khan B Galarraga JJF Belch 2010 The role of endothelial function and its assessment in rheumatoid arthritis Nat Rev Rheumatol 6 253 261 20351705 10.1038/nrrheum.2010.44
6. DH Solomon EW Karlson EB Rimm, et al. 2003 Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 1303 1307 12628952 10.1161/01.CIR.0000054612.26458.B2 (Pubitemid 36314415)
7. J Avouac Y Allanore 2008 Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs Expert Opin Pharmacother 9 1121 1128 18422470 10.1517/14656566.9.7.1121 1:CAS:528:DC%2BD1cXkvVemt74%3D (Pubitemid 351721750)
8. SE Gabriel CS Crowson HM Kremers, et al. 2003 Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years Arthritis Rheum 48 54 58 12528103 10.1002/art.10705 (Pubitemid 36091647)
9. EJ Kroot MA van Leeuwen MH van Rijswijk, et al. 2000 No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset Ann Rheum Dis 59 954 958 11087698 10.1136/ard.59.12.954 1:STN:280:DC%2BD3M7itlaisg%3D%3D
10. DPM Symmons MA Jones DL Scott P Prior 1998 Long term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well J Rheumatol 25 5
11. PA Reilly JA Cosh PJ Maddison AJ Silman 1990 Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients Ann Rheum Dis 49 3 10.1136/ard.49.6.363
12. HM Kremers CS Crowson TM Therneau VL Roger SE Gabriel 2008 High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study Arthritis Rheum 58 2268 2274 18668561 10.1002/art.23650
13. S Manzi EN Meilahn JE Rairie, et al. 1997 Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study Am J Epidemiol 145 408 415 9048514 1:STN:280:DyaK2s3gtVKrtw%3D%3D (Pubitemid 27084212)
14. MM Ward 1999 Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus Arthritis Rheum 42 338 346 10025929 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U 1:STN:280:DyaK1M7kvVOqtA%3D%3D (Pubitemid 29072852)
15. LM Fischer RG Schlienger C Matter H Jick CR Meier 2004 Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction Am J Cardiol 93 198 2000 14715346 10.1016/j.amjcard.2003.09.037 (Pubitemid 38058729)
16. AE Hak EW Karlson D Feskanich MJ Stampfer KH Costenbader 2009 Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study Arthritis Rheum 61 10 1396 1402 19790130 10.1002/art.24537
17. Bartoloni E, Alunno A, Bistoni O, Gerli R (2011) Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy. Clinic Rev Allerg Immunol (in press)
18. L de Groot MD Posthumus CGM Kallenberg M Bijl 2010 Risk factors and early detection of atherosclerosis in rheumatoid arthritis Eur J Clin Investig 40 835 842 10.1111/j.1365-2362.2010.02333.x
19. Z Ozbalkan C Efe M Cesur, et al. 2010 An update on the relationships between rheumatoid arthritis and atherosclerosis Atherosclerosis 212 377 382 20430394 10.1016/j.atherosclerosis.2010.03.035 1:CAS:528:DC%2BC3cXht1OgtbnE
20. SP Johnsen H Larsson RE Tarone, et al. 2005 Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study Arch Intern Med 165 978 984 15883235 10.1001/archinte.165.9.978 1:CAS:528:DC%2BD2MXkvVGjurg%3D (Pubitemid 40638117)
21. I del Rincón DH O'Leary RW Haas A Escalante 2004 Effect of glucocorticoids on the arteries in rheumatoid arthritis Arthritis Rheum 50 3813 3822 15593231 10.1002/art.20661 (Pubitemid 39643928)
22. C García-Gómez JM Nolla J Valverde J Narváez E Corbella X Pintó 2008 High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy Eur J Clin Investig 38 686 692 10.1111/j.1365-2362.2008.01994.x
23. AE van Ede RFJM Laan HJ Blom, et al. 2002 Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis Rheumatol Oxf 41 658 665 10.1093/rheumatology/41.6.658 (Pubitemid 34618884)
24. R Roubenoff P Dellaripa MR Nadeau, et al. 1997 Abnormal homocysteine metabolism in rheumatoid arthritis Arthritis Rheum 40 718 722 9125255 10.1002/art.1780400418 1:STN:280:DyaK2s3ksVejtA%3D%3D (Pubitemid 27157578)
25. MJ Peters DP Symmons D McCarey, et al. 2010 EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Ann Rheum Dis 69 325 331 19773290 10.1136/ard.2009.113696 1:STN:280:DC%2BC3c%2Fls12jtg%3D%3D
26. M Mosca C Tani M Aringer, et al. 2010 European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies Ann Rheum Dis 69 1269 1274 19892750 10.1136/ard.2009.117200 1:STN:280:DC%2BC3critFWjtw%3D%3D
27. RB D'Agostino S Ramachandran MJ Pencina The Framingham Heart Study, et al. 2008 General cardiovascular risk profile for use in primary care Circulation 117 743 753 18212285 10.1161/CIRCULATIONAHA.107.699579 (Pubitemid 351640675)
28. MC Hochberg 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 9 1725 9324032 10.1002/art.1780400928 1:STN:280:DyaK2svmsVaisw%3D%3D
29. J Genest R McPherson J Frohlich, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipiedmia and prevention of cardiovascular disease in the adult-2009 recommendations Can J Cardiol 25 10 567 579 19812802 10.1016/S0828-282X(09)70715-9 1:CAS:528:DC%2BD1MXhtlynsLvF
30. Bell C, Rowe I (2010) The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: a questionnaire-based study of general practitioners. Musculoskeletal Care (in press)
31. SR Brady B de Courten CM Reid FM Cicuttini MP de Courten D Liew 2009 The role of traditional cardiovascualr risk factors among patients with rheumatoid arthritis J Rheumatol 36 1 34 40 19012364
32. M Nikpour MB Urowitz DD Gladman 2009 Epidemiology of atherosclerosis in systemic lupus erythematosus Curr Rheumatol Rep 11 248 254 19691927 10.1007/s11926-009-0035-z